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Abstract
This review discusses about biomimetic medical materials for tissue engineering of bone and cartilage, after
previous scientific commentary of the invitation-based, Korea-China joint symposium on biomimetic medical
materials, which was held in Seoul, Korea, from October 22 to 26, 2015. The contents of this review were evolved
from the presentations of that symposium. Four topics of biomimetic medical materials were discussed from
different research groups here: 1) 3D bioprinting medical materials, 2) nano/micro-technology, 3) surface
modification of biomaterials for their interactions with cells and 4) clinical aspects of biomaterials for cartilage
focusing on cells, scaffolds and cytokines.
Introduction
Scaffolds with bimimetics have been developed for tissue
engineering, based on the sciences and engineering of
biomaterials and nano/microstructures of defect tissues. The
bone and cartilage tissues function according to the physico-
chemical properties and nano/micro-structures of tissues.
Surface and bulk morphologies, defect sizes, extracellular
matrix (ECM) domains, biological molecules and ECM
structures are typical examples of major components and
properties of defect tissues, which require tissue regener-
ation. 3D bioprinting among many technologies in tissue
engineering has been applied to fabrications of scaffolds
based on understanding of tissue morphologies and physico-
chemical properties in nano/micro levels, even though 3D
bioprinting has at current stages many huddles to be over-
come to its clinical applications. Tissue engineering of 3D
printing scaffolds could be clinically accomplished by com-
bining with (stem) cells, possibly with biological agents. In
this review, we in different research groups have briefly dis-
cussed recent research trends in biomimetic medial mate-
rials for tissue engineering such as 3D bioprinting, surface
modification, nano/micro-technology and clinical aspects in
tissue engineering of bone and cartilage. Their backgrounds
are designs of biomaterials in nanotechnology, fabrications
of tissue engineering, surface modification and orthopedic
clinics.
Research trends of biomimetic medical materials: 3D
bioprinting
Tissue engineering is repairing or regenerating diseased
or damaged tissues and organs through implantation of
the combinations of tissue engineering factors such as
cells, scaffolds and biological signals with mechanical
stimuli. Tissue engineering scaffolds provide primarily
3D structures of specific tissues and support tissue
regeneration via cell adhesion, proliferation, and cellular
communications and interactions. Porous polymer
scaffolds for bone and cartilage regeneration have
been traditionally fabricated through the methods of
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gas forming, soluble particle leaching and freeze dry-
ing [1–3]. Those methods have been developed by
using functional chemistries and surface modifications of
polymeric biomaterials. Porous scaffolds of biodegradable
poly(lactide-co-glycolide) were fabricated by gas foaming
of porogens such as ammonium bicarbonate particles. In-
jectable hydrogel was developed by using click chemistry,
showing its advantages such as local delivery of bioactive
molecules, easy handling, minimal invasiveness, and its
potential applications to 3D bioprinting materials [4].
Fabrications of tissue engineering scaffolds have been
recently focused on both utilization of biomimetic of extra-
cellular matrix (ECM) and control of both cellular behaviors
and biosignals. Novel fabrication methods of well-defined
scaffolds have been reported for large tissue defects and
organ replacement by using acellular scaffolds or cellular
constructs [5, 6]. While acellular scaffolds were fabricated
using various techniques such as heat, chemicals, light and
molding, cellular constructs were done by combinations of
cells and mostly photo-printing of hydrogels in 3D printing
to mimic the properties of ECM of bone and cartilage. 3D
printing of scaffolds was achieved by the methods of mater-
ial extrusion, material jetting, binder jetting, sheet lamin-
ation, vat photo-polymerization, powder bed fusion and
direct energy deposition [7, 8]. These methods have their
own pros and cons in their applications to fabricating tissue
engineering scaffolds. Stereolithography and fused depos-
ition methods have disadvantages such as difficulty in
bioprinting of precursor polymer solutions with live cells
due to their damages during printing and side effects of
cross-linking agents during hydrogel formation [9, 10]. In
the case of vat photo-polymerization, active and non-toxic
cross-linking agents are required for hydrogel fabrications,
and at the same time, structural integrity of implanted
scaffolds between scaffold biodegradation and tissue regen-
eration is important over in vivo implant periods. Syringe
extrusion of cells complex during inkjet 3D printing is
achieved by the methods of air pressure, syringe pump and
screw, and cells-containing hydrogel is currently printed
out with a dimension of 100 μm – 1 mm ranges in diame-
ters [11, 12]. While those extrusion methods have advan-
tages such as mechanical properties and possibility of
combinations of biomaterials and cells, they also have lim-
ited properties such as shear stress to the wall of a nozzle
tip and limited choices of hydrogel materials for cell
encapsulation, leading to cells aggregation and damages.
Diverse biomaterials have been developed in 3D bio-
printing of scaffolds [13–16]. While natural polymers such
as collagen, hyaluronic acid, chitosan, cellulose, fibrin,
alginate, agarose, gelatin, laminin and matrigel have been
employed in 3D bioprinting through their chemical modifi-
cations, poly(ethylene glycol) poly(lactide-co-glycolide),
polylactide, polycarprolactone, polyglycolide and poly(vinyl
alcohol) have been employed as synthetic polymers for
tissue engineering of bone and cartilage. Applications of
biomimetics to hydrogel fabrication in bioprinting were
possible by chemical modifications of biocompatible poly-
mers such as poly(ethylene glycol), polycarbonates and
poly(vinyl alcohol) among many synthetic medical poly-
mers. Functional cross-linking of the polymers were pos-
sible through click chemistries such as photo- and thermal
chemistry, Michael type addition reactions, pHs and others
[17–21]. Inorganic biomaterials have been also employed
for 3D printing by controlling the properties of 3D printers
such as fabrication methods and their nozzle sizes and sur-
face properties [22, 23]. Bioactive glass, hydroxyl apatite,
biphasic calcium phosphate, hydroxyphosphate calcium
and tricalcium phosphate were normally employed as inor-
ganic biomaterials in 3D printing of scaffold for tissue en-
gineering. Recently, combinations of those polymers and
ceramics have been tried to optimize their properties for
3D bioprinting.
Combination of 3D bioprinting and micro/nano-tech-
nology has been utilized in tissue engineering area, being
considered as a unique technology to overcome the issues
of fabrications of biomimetic scaffolds for complex tissues.
Nano/micro-technology has been employed for designs of
scaffolds as described in following session. Controlling of
porosity, permeability, surface properties, initial mechan-
ical properties, and biodegradation of repeating units in
polymer’s backbone chains are examples of employment
of nano/micro-technology in scaffold designs [24–27]. 3D
bioprinting uses hydrogel as a cell carrier and requires
properties such as high cell viability, surface tension, water
contents and printability with high resolution with tens to
hundreds of μm [28]. It provides new approaches towards
better and smarter tissue engineering that have the possi-
bility to profoundly impact therapeutic regenerative medi-
cine through better biomimetics of specific tissue
structures by nano/micro-technology. Since cells and their
components are in the ranges of tens to hundreds micro-
meters to nano-meters, cell-biomaterials interactions are
affected by those ranges, indicating the importance of
biomaterials designs and fabrications through combin-
ation of micro/nano-technology and biomimetics. Import-
ant factors in biomimetics-based scaffolds designs could
be controlled delivery of bioactive molecules, fabrications
of right pore size, volume and geometry similar to target
ECM as well as biomaterials compositions and physical/
chemical properties of the scaffolds [29–32]. Biomimetic
scaffolds have been reported having defined mechanical/
structural properties of bone tissues such as properties of
the cancellous bone’s 50 – 90 volume % porosity and the
cortical bone’s dense outer layer of bone with less than 10
volume % [11, 12]. In cartilage, example of combination of
biomimetics and nano/micro-technology is designing the
structures of cartilage tissues through 3D bioprinting as
well as their bio-related chemical and mechanical
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functions [30]. These functional designs of scaffolds with
controlled delivery of biosignals have been expected to
lead to better regeneration of various zones of osteochon-
dral ECM.
Even though remarkable progresses was made in tissue
engineering by using both 3D bioprinting and nano/micro-
technology, there are still huddles, such as the issues of
adequate printable biomaterials, biocompatibility, structural
stability, biodegradation and immunology, to be overcome
in the area of clinical applications to tissue engineering of
bone and cartilage among many target tissues. Better
cooperation of biomaterials scientists, engineers and clini-
cians should be made to achieve progress of 3D bioprinting
and bone and cartilage tissue engineering.
Research trends of biomimetic medical materials: micro/
nano-patterning technology
There exist largely two approaches to make micro/nano
patterns. One is top-down approaches; They use usually
the templates which are fabricated through UV photolith-
ography, nanolithography [33–35] such as e-beam lithog-
raphy, nanoimprint lithography and focused ion beam
(FIB) milling, and so on. However, the nanolithography-
based top-down approaches for nanoscale patterns suffer
from low throughput and high cost. Therefore, a simple
and cost-effective process with high throughput is
required for the fabrication of well-defined micro/nano
patterns. The other approaches, which are called as
bottom-up approaches, are generally free from complex
template fabrication. They include electrospinning, self-
assembly, wrinkle and crack through PDMS stretching,
electrodeposition and sol-gel synthesis with anodic
aluminum oxide (AAO) or copolymer templates [36–41].
They can make micro/nano patterns in a simple, high-
throughput and cost-effective manner, but suffer from
obtaining the ordered and reproducible patterns when
compared with those of the top-down approaches.
Many researches have been reported about development
of micro/nano patterns for biomedical applications using
both top-down and bottom-up approaches [42–45]. Spe-
cially, polymer-based micro/nano patterns have been widely
used for those fields because polymer-based materials have
the advantages of low cost, good biocompatibility, high op-
tical clarity and high impact strength [46–48]. Recently,
biological materials such as diatom [47] and galium aparine
[48] are increasingly used as templates for replica molding
process, which enable us to fabricate micro/nano patterns
and features with low-cost and high reliability. Also, con-
ventional direct etching process to biomedical materials
such as titanium (Ti) is effective to obtain micro/nano
structures on its surface [49]. The successful construction
of micro/nano-textured surface on a Ti substrate could in-
duce cell adhesion and proliferation efficiently. Recently,
nanostructured biomaterials with physical nano-features
(nanocrystals, nanofibers, nanocomposites, etc.) have been
widely studied in the fields of regenerative medicine due to
the resemblance of physical nano-features to natural ECM
[50, 51]. Since natural biological tissues, organs and cells
have nanoscale features, the biomimetic features and excel-
lent physicochemical properties of nanostructured bioma-
terials play a key role in stimulating cell growth as well as
guiding tissue regeneration [52]. Therefore, the surface de-
signs in nanoscale and molecular level are very important
in developing new functional biomaterials.
Biomimetic medical materials trends: surface
modifications
Natural materials like bone, ligaments, wood, shells, and
scales are remarkably efficient in terms of fulfilling
complex and multiple functional requirements [53]. The
development of biomaterials has recently focused on the
design of biomimetic materials that are capable of eliciting
specific cellular responses and directing new tissue forma-
tion mediated by bioactive molecules recognition, which
can be manipulated by altering design parameters of the
material [54]. For example, an implant associates osteoin-
ductive biomolecules, such as growth factors, hormones,
enzymes and DNAs, with osteoconductive calcium phos-
phates, could regulate and accelerate the bone formation.
Extensive studies have been performed to render
materials’ biomimetic. The surface modification of bio-
materials with bioactive molecules is a simple way to
make biomimetic materials [55]. There are various tech-
niques to immobilize bioactive molecules onto the sur-
faces of biomaterials, including physical adsorption [56],
chemically covalent bonding [57], and biomimetic
incorporation [58]. Biomimetic coating has been first
introduced by Kokubo in 1990s through soaking alkali
treated implants in a simulated body fluid (SBF: ion con-
centrations similar to human blood plasma) resulting in
growth of a bone-like apatite layer [59]. The generated
minerals, being biodegradable, porous, and microcrystal-
line, have the ability to load bioactive molecules onto
substrate without compromising their bioactivity. As
consequence, the bioactive molecules are truly incorpo-
rated into the crystal lattice, not superficially adsorbed
upon surfaces. The molecules are released gradually
from these coating, rather than in a single rapid burst.
One remarkable advantage of the biomimetic coating is
that it can even grow on three-dimensional scaffolds.
Surface modification with bioactive molecules offers the
potential to control cell behavior only on the surface of bio-
medical devices. With bulk modification of biomaterials,
bioactive molecules are incorporated into the biomaterials
and the resulting recognition sites are present not only on
the surface but also in the materials [60]. It is well known
that the formation of a turban shell includes a process
where inorganic minerals deposited on assembled organic
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proteins from an aqueous solution at mild temperature and
pressure [61]. If this type of biomimetic approach could be
reproduced, then the bioactive molecules could be incorpo-
rated stably in inorganic materials without losing their bio-
logical activity [62]. Various bioactive molecules, such as
collagen [63], silk fibroin [64], dentin matrix protein 1 [65],
chitosan [66], alginate [67], peptide-amphiphile molecular
[68], have been served as templates to regulate the growth
of inorganic crystals. The structures of the templates play a
vital role in controlling the morphologies of the inorganic
crystals [69]. For example, fibrous templates lead to a
needle-like hydroxyapatite [70], while spherical templates
result in sheet-like hydroxyapatite [71]. Simultaneous ap-
plying different templates in the system may lead to more
sites of nucleation compared with a single-template system,
which may affect the orientation, size, and morphology of
regulated inorganic crystal.
Biomimetic medical materials with immobilized bio-
active molecules possess unique properties of organic
and inorganic components in one material for academic
research as well as for the development of innovative in-
dustrial applications. Thus, the surface modification of
metal or bulk modification of ceramic with bioactive
molecules is necessary to produce high-performance
biomimetic medical materials.
Recent research trends of articular cartilage repair: cells,
scaffolds and cytokines
The predominant approach for tissue regeneration is cell
delivery, either by transplantation of progenitor cells or
more mature cells. Many cell sources have been ex-
plored for the treatment of cartilage defect whether they
are either autologous or allogenic. Autologous cells that
are clinically available for articular cartilage repair are
chondrocytes. Autologous chondrocyte implantation
(ACI) was first published in 1994 by Brittberg and it has
been expected to show far better results than the mar-
row stimulating procedure [72, 73]. Autologous chon-
drocyte implantation, however, was also not perfect and
showed the results comparable to or slightly better than
those of marrow stimulating procedure in several studies
[74]. Fibrous cartilage regeneration, difficulty in proced-
ure and high cost for cell preparation are hurdles in
widespread use of this technique [75]. More cell sources
including autologous bone marrow cells and adipose
stem cells are under investigation and clinical trials, al-
though the evidences are limited so far [76]. Cartilage itself
has been shown to have stem cell fraction in their matrix,
but they are too few and little has been known about their
biological potentials in regenerating tissue [77].
Allogenic cells can be used after ex vivo culture and con-
sidered to be different from autologous cells in their behav-
iors in vivo [78]. These allogenic cells remain as an
attractive alternative that circumvents the problem of
donor cell shortage. There are, however, technical problems
such as immunogenicity, pathogen transmission and mis-
match of donor-host micro-environment, which should be
resolved prior to clinical applications. Recently allogenic
cord blood stem cells have been commercialized in Korea
to repair articular cartilage repair for chondral defects as
well as degenerative articular diseases. Although the effi-
cacy compared with other regenerative techniques is still in
questions, its safety and the minimal efficacy have been ac-
cepted by the government agency for permission to be used
for patients with chondral defects.
In contrast to the exogenously administered/injected
cells, a micro-fracture technique has been considered as
a representative surgical procedure that uses endogenous
cells in cartilage repair [79]. Simple micro-fractures or
subchondral drilling provides a complete set of constitu-
ents required for tissue-engineered cartilage regener-
ation theoretically. However, incomplete healing of the
defects, deterioration of the fibrocartilage, and subchon-
dral bone hypertrophy after micro-fracture resulted in
unsatisfactory clinical outcomes that necessitated im-
provement of the methods or the development of novel
sources of constituents [80, 81]. Various biomaterials
scaffolds that provide temporary compartment to retain
cells and enable diffusion of vital nutrients were devel-
oped to enhance potentials of tissue regeneration by
micro-fracture techniques [82]. Autologous bone mar-
row cells can be harvested from ilium, concentrated and
then applied, thus providing higher number of cells to
participating tissue regeneration [83]. Their results are
controversial and well-designed level 1 studies are
scarce, but several promising results showed potentials
of their applications. It is still controversial whether the
cultured chondrocytes are better than endogenous bone
marrow cells. Several randomized clinical trials showed
no differences in outcomes between micro-fracture and
ACI, while others did although it is small [84].
Polymeric biomaterials scaffolds were used to elimin-
ate complications and to promote the outcomes of ACI
[85]. Collagen sheets and hyaluronic acid gels among
other scaffolds were expected to reduce the hypertrophic
complications of periosteum that was used for ACI. In
general, the 2nd and 3rd generation ACIs that used bio-
material scaffolds showed tendency toward better out-
come than its 1st generation did. Scaffolds such as
hyaluronan have been used to enhance the outcomes of
micro-fracture. Autologous matrix-induced chondrogen-
esis (AMIC) showed better mid to long term results
than micro-fracture only did [82].
Collagen and fibrin also function as bioactive cues like
growth factors or cell recruitment factors. Bioactive cues
to initiate and enhance the regeneration potential have
been considered as one of the most important issues that
should be addressed. Whereas the cell transplantation is
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still the predominant approach, emerging studies have
shown enhanced potentials of host endogenous cells. Cell
homing is the concept that cells such as mesenchymal
stem cells (MSCs) migrate to injured tissue as MSCs
express various chemokine receptors and adhesion mole-
cules [86]. Its attracting factors are numerous. Recently an
acellular ‘smart’ scaffold with TGF-β3 has been reported to
regenerate whole synovial joint including bone, cartilage
and synovium [87]. Also, poly(lactide-co-glycolide) (PLGA)
scaffolds seeded with autologous endothelial progenitor
cells have shown to repair a full-thickness osteochondral
defect in rabbits [88].
Cell transplantation and cell homing are not exclusive
each other in cartilage tissue engineering. Furthermore,
engineered scaffolds are required to provide a provisional
space for effective tissue regeneration as well as manipula-
tion of appropriate bio-environments.
Conclusions
Four topics of biomimetic medical materials from differ-
ent research groups with different backgrounds have
been discussed such as 1) 3D bioprinting focusing on
medical materials, 2) designs of nano/micro-technology,
3) surface modification of biomaterials for their interac-
tions with cells, and 4) clinical aspects of biomaterials
for cartilage focusing on cells, scaffolds and cytokines.
Even though traditional methods of fabrications of tissue
engineering scaffolds have still many advantages, 3D
printing methods and right biomaterials have been
emerged as extremely important factors in tissue engin-
eering, where both designs of biomaterials in micro/
nano levels and surface modifications have acted as the
basic technologies in designs of biomimetic materials.
Combination of 3D printing and stem cells are
extremely important to tissue engineering of bone and
cartilage tissues.
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